Capstone Investment Advisors’s PharMerica Corporation PMC Stock Holding History

Capstone Investment Advisors’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-150,000	Closed	-$4.39M	–	746
2017 Q3	$4.39M	Buy	+150,000	New	+$4.2M	0.15%	112
2016 Q3	–	Sell	-12,900	Closed	-$318K	–	992
2016 Q2	$318K	Buy	+12,900	New	+$320K	0.01%	554

Capstone Investment Advisors's PMC Position: Q4 2017 in Review

Capstone Investment Advisors sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 150,000 shares — an estimated $4.39M sold.

Capstone Investment Advisors first reported a position in PMC in Q2 2016 and held it in 2 quarters. The position peaked at $4.39M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.

Capstone Investment Advisors reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
Capstone Investment Advisors sold 150,000 PharMerica Corporation shares in Q4 2017, an estimated $4.39M.
Capstone Investment Advisors first reported a position in PharMerica Corporation in Q2 2016 and held it in 2 quarters.
Capstone Investment Advisors's PharMerica Corporation position peaked at $4.39M in Q3 2017.
0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.

Based on Capstone Investment Advisors's 13F filing for Q4 2017, filed 14 Feb 2018.